Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.

Igarashi A, Kuwabara H, Fahrbach K, Schenkel B.

J Dermatolog Treat. 2013 Oct;24(5):351-5. doi: 10.3109/09546634.2012.697111. Epub 2012 Jul 9. Review.

PMID:
22632451
[PubMed - indexed for MEDLINE]
2.

Cost effectiveness of biologic therapies for plaque psoriasis.

Ahn CS, Gustafson CJ, Sandoval LF, Davis SA, Feldman SR.

Am J Clin Dermatol. 2013 Aug;14(4):315-26. doi: 10.1007/s40257-013-0030-z. Review.

PMID:
23696234
[PubMed - indexed for MEDLINE]
3.

Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis.

Liu Y, Wu EQ, Bensimon AG, Fan CP, Bao Y, Ganguli A, Yang M, Cifaldi M, Mulani P.

Adv Ther. 2012 Jul;29(7):620-34. doi: 10.1007/s12325-012-0035-7. Epub 2012 Jul 27.

PMID:
22843208
[PubMed - indexed for MEDLINE]
4.

Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis.

Ferrándiz C, García A, Blasco AJ, Lázaro P.

J Eur Acad Dermatol Venereol. 2012 Jun;26(6):768-77. doi: 10.1111/j.1468-3083.2011.04357.x. Epub 2011 Nov 30.

PMID:
22126264
[PubMed - indexed for MEDLINE]
5.

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.

Reich K, Burden AD, Eaton JN, Hawkins NS.

Br J Dermatol. 2012 Jan;166(1):179-88. doi: 10.1111/j.1365-2133.2011.10583.x. Epub 2011 Nov 11. Review.

PMID:
21910698
[PubMed - indexed for MEDLINE]
6.

Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece.

Avgerinou G, Bassukas I, Chaidemenos G, Katsampas A, Kosmadaki M, Kousoulakou H, Petridis A, Schenkel B, Sotiriadis D, Spiliopoulos T, Stavropoulos P, Toumpi E, Xaplanteris L.

BMC Dermatol. 2012 Jul 25;12:10. doi: 10.1186/1471-5945-12-10.

PMID:
22831458
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Biological treatments for moderate-to-severe psoriasis: indirect comparison.

Galván-Banqueri M, Marín Gil R, Santos Ramos B, Bautista Paloma FJ.

J Clin Pharm Ther. 2013 Apr;38(2):121-30. doi: 10.1111/jcpt.12044. Epub 2013 Feb 26.

PMID:
23442134
[PubMed - indexed for MEDLINE]
8.

Economic evaluation of systemic therapies for moderate to severe psoriasis.

Sizto S, Bansback N, Feldman SR, Willian MK, Anis AH.

Br J Dermatol. 2009 Jun;160(6):1264-72. doi: 10.1111/j.1365-2133.2008.08962.x. Epub 2008 Dec 15.

PMID:
19120346
[PubMed - indexed for MEDLINE]
9.

Adalimumab for the treatment of psoriasis.

Turner D, Picot J, Cooper K, Loveman E.

Health Technol Assess. 2009 Sep;13 Suppl 2:49-54. doi: 10.3310/hta13suppl2/07. Review.

PMID:
19804689
[PubMed - indexed for MEDLINE]
Free Article
10.

[Efficiency of biologic agents in the treatment of moderate to severe psoriasis].

Blasco AJ, Lázaro P, Ferrándiz C, García-Díez A, Liso J.

Actas Dermosifiliogr. 2009 Nov;100(9):792-803. Spanish.

PMID:
19889301
[PubMed - indexed for MEDLINE]
11.

Biologics in the treatment of psoriasis: clinical and economic overview.

Poulin Y, Langley RG, Teixeira HD, Martel MJ, Cheung S.

J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S49-57. Review.

PMID:
19799827
[PubMed - indexed for MEDLINE]
12.

Etanercept and efalizumab for the treatment of psoriasis: a systematic review.

Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Vergel YB, Misso K, Light K, Chalmers R, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. Review.

PMID:
17083854
[PubMed - indexed for MEDLINE]
Free Article
13.

Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.

Bonafede M, Joseph GJ, Princic N, Harrison DJ.

J Med Econ. 2013 Sep;16(9):1120-8. doi: 10.3111/13696998.2013.820192. Epub 2013 Jul 18.

PMID:
23808901
[PubMed - indexed for MEDLINE]
14.

Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.

Martin S, Feldman SR, Augustin M, Szapary P, Schenkel B.

J Dermatolog Treat. 2011 Jun;22(3):138-43. doi: 10.3109/09546634.2010.542800. Epub 2011 Jan 22.

PMID:
21254886
[PubMed - indexed for MEDLINE]
15.

Costs of therapy with biologics in the treatment of moderate to severe plaque psoriasis in the context of the Italian health-care system.

Terranova L, Mattozzi C, Richetta AG, Mantuano M, Cardosi L, Teruzzi C.

G Ital Dermatol Venereol. 2014 Feb;149(1):131-43.

PMID:
24566574
[PubMed - indexed for MEDLINE]
16.

Ustekinumab for the treatment of moderate to severe psoriasis.

Gospodarevskaya E, Picot J, Cooper K, Loveman E, Takeda A.

Health Technol Assess. 2009 Oct;13 Suppl 3:61-6. doi: 10.3310/hta13suppl3/10. Review.

PMID:
19846031
[PubMed - indexed for MEDLINE]
Free Article
17.

[Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials].

Zhang Z, Schmitt J, Wozel G, Kirch W.

Med Klin (Munich). 2009 Feb 15;104(2):125-36. doi: 10.1007/s00063-009-1024-8. Epub 2009 Feb 26. German.

PMID:
19242664
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.

Schmitt J, Zhang Z, Wozel G, Meurer M, Kirch W.

Br J Dermatol. 2008 Sep;159(3):513-26. doi: 10.1111/j.1365-2133.2008.08732.x. Epub 2008 Jul 9. Review.

PMID:
18627372
[PubMed - indexed for MEDLINE]
19.

Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis.

Bonafede MM, Gandra SR, Watson C, Princic N, Fox KM.

Adv Ther. 2012 Mar;29(3):234-48. doi: 10.1007/s12325-012-0007-y. Epub 2012 Mar 9.

PMID:
22411424
[PubMed - indexed for MEDLINE]
20.

Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital.

Noda S, Mizuno K, Adachi M.

J Dermatol. 2012 Mar;39(3):265-8. doi: 10.1111/j.1346-8138.2011.01312.x. Epub 2011 Nov 29.

PMID:
22126280
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk